WO2001058519A1 - Implantable stimulation lead - Google Patents

Implantable stimulation lead Download PDF

Info

Publication number
WO2001058519A1
WO2001058519A1 PCT/US2001/001559 US0101559W WO0158519A1 WO 2001058519 A1 WO2001058519 A1 WO 2001058519A1 US 0101559 W US0101559 W US 0101559W WO 0158519 A1 WO0158519 A1 WO 0158519A1
Authority
WO
WIPO (PCT)
Prior art keywords
lead
lead body
percutaneous
stimulation
electrode
Prior art date
Application number
PCT/US2001/001559
Other languages
French (fr)
Other versions
WO2001058519A9 (en
Inventor
Thomas E. Cross, Jr.
Original Assignee
Medtronic, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medtronic, Inc. filed Critical Medtronic, Inc.
Priority to DE60111723T priority Critical patent/DE60111723T2/en
Priority to EP01951125A priority patent/EP1257320B1/en
Publication of WO2001058519A1 publication Critical patent/WO2001058519A1/en
Publication of WO2001058519A9 publication Critical patent/WO2001058519A9/en

Links

Classifications

    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01R—ELECTRICALLY-CONDUCTIVE CONNECTIONS; STRUCTURAL ASSOCIATIONS OF A PLURALITY OF MUTUALLY-INSULATED ELECTRICAL CONNECTING ELEMENTS; COUPLING DEVICES; CURRENT COLLECTORS
    • H01R13/00—Details of coupling devices of the kinds covered by groups H01R12/70 or H01R24/00 - H01R33/00
    • H01R13/02—Contact members
    • H01R13/025—Contact members formed by the conductors of a cable end
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/40—Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4029—Detecting, measuring or recording for evaluating the nervous system for evaluating the peripheral nervous systems
    • A61B5/4041—Evaluating nerves condition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0551—Spinal or peripheral nerve electrodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/22—Arrangements of medical sensors with cables or leads; Connectors or couplings specifically adapted for medical sensors
    • A61B2562/225—Connectors or couplings
    • A61B2562/227—Sensors with electrical connectors
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01R—ELECTRICALLY-CONDUCTIVE CONNECTIONS; STRUCTURAL ASSOCIATIONS OF A PLURALITY OF MUTUALLY-INSULATED ELECTRICAL CONNECTING ELEMENTS; COUPLING DEVICES; CURRENT COLLECTORS
    • H01R2201/00—Connectors or connections adapted for particular applications
    • H01R2201/12—Connectors or connections adapted for particular applications for medicine and surgery

Definitions

  • the present invention relates to surgical lead bodies which provide electrical stimulation to nerve tissue of a patient. More particularly, but without restriction to the particular use which is shown and described, the present invention relates to a surgical lead body having a minimum cross section such that the surgical lead body may be percutaneously implanted through a modified Tuohy needle having an oblong shaped opening.
  • nerve tissue stimulation is used to treat numerous neurological disorders, including, but not limited to, cerebral palsy, multiple sclerosis, amyotrophic lateral sclerosis, dystonia, and torticollis. It is further known that nerve tissue stimulation is useful to treat intractable malignant and nonmalignant pain. Stimulation of nerve tissue of the spinal cord, for example, is often accomplished through implanted medical leads in the epidural space of the spinal cavity.
  • the implanted lead defines a lead body which includes neural stimulation electrodes that conduct electrical stimulation signals from a stimulation source, such as implantable pulse generators, to targeted nerve fibers in the epidural space.
  • These medical leads may be percutaneous lead bodies which have a cylindrical shape with cylindrical electrodes spaced along the body of the lead. Also, the medical leads may be surgical lead bodies with electrodes spaced in an array on a paddle-type lead body.
  • the percutaneous lead body is introduced into the epidural space of the spinal cord using a needle and stylet.
  • the needle commonly referred to as a Tuohy needle
  • stylet are inserted into the targeted spinal column area between adjacent vertebrae until the tip of the needle and stylet are positioned into the epidural space.
  • the stylet is withdrawn and a percutaneous lead body is inserted through the opening or lumen of the needle into the epidural space and positioned at the targeted stimulation area.
  • the needle is then withdrawn leaving the percutaneous lead body in the desired stimulation position.
  • Drawbacks encountered with known percutaneous lead bodies include migration or movement of the lead body after it is implanted.
  • the cylindrical shape of the electrode in the percutaneous lead body generates omni-directional stimulation instead of one-directional, focused stimulation.
  • the surgical lead body which is typically a paddle-type lead body often has a rectangular, flat cross-section. Spaced in an array on one side of the paddle are the electrodes. The array of electrodes provides better stimulation coverage of the targeted nerve tissue than a percutaneous lead body. In contrast to the percutaneous lead body, however, the surgical lead body is surgically implanted into the epidural space. This requires a physician to perform a laminotomy, laminectomy, or similar procedure, prior to the insertion of the surgical lead into the epidural space. Once implanted, the surgical lead having the flat, rectangular shape is generally more stable than a percutaneous lead and provides one-directional stimulation — stimulation more focused than a percutaneous lead body.
  • a drawback with the surgical lead body is the performance of a laminotomy or similar surgical procedure. Anesthesiologists who frequently provide the nerve tissue stimulation for a patient are often prevented from using the surgical lead body as the laminotomy procedure is generally outside the scope of their practice.
  • an implantable lead body that provides the advantages of the surgical lead body but does not require performing a laminotomy, or other surgical procedure, prior to implantation. It is another object of the present invention to provide a lead body that may be percutaneously implanted at the targeted nerve tissue. It is yet another object to provide a lead body having the stability of a surgical lead. Another object is to provide a lead body having an array of spaced electrodes for better stimulation coverage of the targeted nerve tissue. Still another object of the present invention is to provide a lead body having one-directional, focused stimulation.
  • the present invention comprises bonding together two percutaneous lead bodies, resulting in the functional equivalent of a surgical lead body.
  • the inventive medical lead body forms columns of electrodes which are either adjacent to or offset from each other, thus forming an array of electrodes.
  • the bonding of the percutaneous lead bodies is accomplished by a plurality of urethane bridges molded to each of the percutaneous lead bodies.
  • the plurality of bridges provides structural integrity to the medical lead yet permits the desired flexibility of the lead body.
  • One side of the inventive medical lead body is "masked" or coated with a suitable non-conductive material. The masking of one side of the medical lead body makes that side of the lead body non-conductive and effectively directs the stimulation signals transmitting from the cylindrical electrodes toward the desired stimulated area for focused stimulation.
  • the medical lead body of the present invention may be percutaneously implanted.
  • the percutaneous implantation is achieved by inserting the inventive medical lead body through a modified Tuohy needle having an oblong cross-section or other similar needle, such as, the needle disclosed in U.S. Patent Application Serial No. 09/303,045, which is incorporated herein by reference.
  • a modified Tuohy needle having an oblong cross-section or other similar needle such as, the needle disclosed in U.S. Patent Application Serial No. 09/303,045, which is incorporated herein by reference.
  • Fig. 1 is an isometric view of the surgical lead of the present invention.
  • Fig. 2 is an enlarged isometric view of the lead of Fig. 1 illustrating the position of the electrodes and the urethane bridge.
  • Fig. 3 is an enlarged isometric view of an alternative embodiment of the lead of Fig. 1.
  • Fig. 4 is an enlarged isometric view of one of the percutaneous lead bodies of Fig. 1 illustrating a possible location of the non-conductive coating (the coating is slightly removed for clarity).
  • Fig. 5 is an enlarged cross-section view of Fig. 2 taken at line 5-5 illustrating a possible location of the non-conductive coating.
  • Fig. 6 is an enlarged cross-section view of Fig. 2 taken at line 6-6 illustrating the urethane bridge.
  • Fig. 7 is an enlarged cross-section view of Fig. 2 taken at line 5-5 illustrating an alternative location and application of the non-conductive coating (the coating is slightly removed for clarity).
  • a preferred embodiment of the medical lead 10 of the present invention useful for spinal cord, deep brain and peripheral nerve stimulation.
  • the inventive medical lead 10 has a sufficiently small cross-section so as to permit percutaneous implantation of the lead at a targeted stimulation area via a modified Tuohy needle having an oblong cross-section.
  • the medical lead 10 provides the advantages of a surgical paddle-type lead, such as, better stimulation coverage and improved stability, without a physician or anesthesiologist having to perform a laminotomy or other similar surgical procedure to implant the medical lead.
  • the medical lead 10 includes a pair of percutaneous lead bodies 12, 14 which are joined together in parallel relation along the edges of each lead.
  • the lead bodies 12, 14 may be molded as a one-piece body depending on desired rigidity of the lead 10, more fully discussed below.
  • each of the lead bodies 12, 14 define a cylindrical lead body and a round end.
  • the lead body is made from polyurethane or other suitable material.
  • Spaced along each of the lead bodies 12, 14 is at least one electrode 16 to provide electrical stimulation to the targeted nerve tissue.
  • Each electrode is typically cylindrical in shape and thus provides stimulation in all directions away from the lead body. It should be understood that other shapes and types of electrodes may be used with the present invention and still be considered to be within the scope of the same.
  • Each of the lead bodies 12, 14 further include at least one wire conductor, not shown, connected to the electrodes. As conventional, each wire conductor of the lead bodies
  • the 12, 14 may be coupled to an implantable neurological pulse generator, additional, intermediate wiring, or other stimulation device.
  • the stimulation pulses produced by the implantable neurological pulse generator or other stimulation device are carried from the pulse generator through the wire conductors to the electrodes in each lead body 12, 14 and out to the targeted tissue.
  • the plurality of electrodes permits varying stimulation of the targeted area. That is, one or more of the electrodes on the lead bodies 12, 14 transmit the stimulation pulses to targeted human tissue depending on the desired stimulation.
  • the percutaneous lead bodies 12, 14 are joined in parallel relation and bonded together by a urethane material, such as polyurethane or other suitable material.
  • the bonding is preferably achieved by a plurality of urethane bridges 20 spaced along the lead bodies. It should be noted that other attachments or means for bonding the lead bodies may be used with the present invention.
  • the preferred urethane bridges 20 are molded to the lead bodies 12, 14 through a heating process not pertinent to the present invention. The spaced apart location of the bridges 20 creates a sufficiently rigid lead assembly that may be inserted through the needle and yet is flexible for enhanced positioning at the targeted area for effective stimulation coverage.
  • the percutaneous lead bodies 12, 14 may be molded as a single lead, thereby effectively creating a single, continuous urethane bridge between the lead bodies, a bridge extending the full length of the lead bodies 12, 14.
  • Fig. 2 there is shown one embodiment of the positioning of the percutaneous lead body 12 relative to the percutaneous lead body 14 for controlled orientation of the electrodes 16 of the lead bodies.
  • the electrodes 16 on lead body 12 are positioned substantially adjacent to the electrodes 16 on lead body 14. Adjacent electrodes may be in contact with each other or may be spaced apart from each other. Note that the contacting electrodes may be in physical contact with each other but not in electrical contact due to masking of one of the electrodes between the adjacent electrodes, as exemplified in Fig. 5.
  • the lead bodies 12, 14 carrying the contacting electrodes may be connected to each other via one or more urethane bridges. Alternatively, the lead bodies may be connected via a single continuous urethane bridge, as described above. In the same manner, the lead bodies 12, 14 carrying the spaced apart electrodes may be connected to each other via either one or more urethane bridges or a single continuous bridge.
  • the lead bodies 12, 14 may be positioned such that the electrodes 16 are off-set or staggered relative to each other.
  • the urethane bridges are positioned between the electrodes.
  • the embodiment of staggered electrodes creates a more rigid structure than the embodiment where the electrodes are positioned adjacent to each other.
  • the number and location of the urethane bridges further affects the rigidity of the lead 10.
  • the electrodes form an array and are spaced both laterally and longitudinally from each, similar to a surgical paddle-type lead. This array provides the advantages of the surgical lead, namely, stimulation coverage of a larger targeted area and varying stimulation of the nerve tissue.
  • the medical lead 10 of the present invention defines two sides. As exemplified in Figure 4, applied to either of the sides is a non-conductive coating 18, preferably a polyurethane, parylene, or similar type coating or paint.
  • the lead functions in a manner similar to the surgical paddle-type lead where the electrical signal is transmitted in only one direction.
  • the amount of coating and the electrode area covered by the coating may vary, as exemplified in Fig. 7.
  • the medical lead 10 is implanted with the non-coated side of the medical lead 10 placed adjacent to the targeted tissue.
  • one or more percutaneous lead bodies may be bonded to either of the percutaneous lead bodies 12, 14. These additional lead bodies may be bonded in a manner similar to the bonding described above.
  • a third percutaneous lead body may be percutaneously positioned alongside the bonded lead bodies 12, 14 and may be used to provide electrical stimulation similar to that taught by the Holsheimer model disclosed in U.S. Patent Nos. 5,501,703 and 5,643,330, both owned by Medtronic, Inc. of Minneapolis, MN, and both incorporated herein by reference. Therefore, to particularly point out and distinctly claim the subject matter regarded as the invention, the following claims conclude the specification.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Cardiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physiology (AREA)
  • Electrotherapy Devices (AREA)

Abstract

There is disclosed a surgical lead which provides electrical stimulation to nerve tissue comprising two percutaneous lead bodies (12, 14) bonded together. The inventive lead body (10) results in the equivalent of a surgical lead body with columns of electrodes either adjacent to or offset from each other. A bridge (20) of urethane material is used to bond together the percutaneous lead bodies and still provide suitable flexibility of the lead. The surface of the electrodes may be coated, in part, with a suitable non-conductive coating (18) to effectively direct the electrical stimulation signals toward the targeted stimulation area. Significantly, the resulting lead is sized to fit within a needle having a similar cross-section, thereby permitting the percutaneous implantation of the inventive lead.

Description

IMPLANTABLE STIMULATION LEAD
BACKGROUND OF THE INVENTION
Field of the Invention
The present invention relates to surgical lead bodies which provide electrical stimulation to nerve tissue of a patient. More particularly, but without restriction to the particular use which is shown and described, the present invention relates to a surgical lead body having a minimum cross section such that the surgical lead body may be percutaneously implanted through a modified Tuohy needle having an oblong shaped opening. Description of the Related Art
It is known that nerve tissue stimulation is used to treat numerous neurological disorders, including, but not limited to, cerebral palsy, multiple sclerosis, amyotrophic lateral sclerosis, dystonia, and torticollis. It is further known that nerve tissue stimulation is useful to treat intractable malignant and nonmalignant pain. Stimulation of nerve tissue of the spinal cord, for example, is often accomplished through implanted medical leads in the epidural space of the spinal cavity. The implanted lead defines a lead body which includes neural stimulation electrodes that conduct electrical stimulation signals from a stimulation source, such as implantable pulse generators, to targeted nerve fibers in the epidural space. These medical leads may be percutaneous lead bodies which have a cylindrical shape with cylindrical electrodes spaced along the body of the lead. Also, the medical leads may be surgical lead bodies with electrodes spaced in an array on a paddle-type lead body.
As conventional, the percutaneous lead body is introduced into the epidural space of the spinal cord using a needle and stylet. The needle (commonly referred to as a Tuohy needle) and stylet are inserted into the targeted spinal column area between adjacent vertebrae until the tip of the needle and stylet are positioned into the epidural space. The stylet is withdrawn and a percutaneous lead body is inserted through the opening or lumen of the needle into the epidural space and positioned at the targeted stimulation area. The needle is then withdrawn leaving the percutaneous lead body in the desired stimulation position. Drawbacks encountered with known percutaneous lead bodies include migration or movement of the lead body after it is implanted. In addition, the cylindrical shape of the electrode in the percutaneous lead body generates omni-directional stimulation instead of one-directional, focused stimulation.
The surgical lead body which is typically a paddle-type lead body often has a rectangular, flat cross-section. Spaced in an array on one side of the paddle are the electrodes. The array of electrodes provides better stimulation coverage of the targeted nerve tissue than a percutaneous lead body. In contrast to the percutaneous lead body, however, the surgical lead body is surgically implanted into the epidural space. This requires a physician to perform a laminotomy, laminectomy, or similar procedure, prior to the insertion of the surgical lead into the epidural space. Once implanted, the surgical lead having the flat, rectangular shape is generally more stable than a percutaneous lead and provides one-directional stimulation — stimulation more focused than a percutaneous lead body. A drawback with the surgical lead body, however, is the performance of a laminotomy or similar surgical procedure. Anesthesiologists who frequently provide the nerve tissue stimulation for a patient are often prevented from using the surgical lead body as the laminotomy procedure is generally outside the scope of their practice.
SUMMARY OF THE INVENTION Accordingly, it is an object of the present invention to provide an implantable lead body that provides the advantages of the surgical lead body but does not require performing a laminotomy, or other surgical procedure, prior to implantation. It is another object of the present invention to provide a lead body that may be percutaneously implanted at the targeted nerve tissue. It is yet another object to provide a lead body having the stability of a surgical lead. Another object is to provide a lead body having an array of spaced electrodes for better stimulation coverage of the targeted nerve tissue. Still another object of the present invention is to provide a lead body having one-directional, focused stimulation.
Briefly, in summary, the present invention comprises bonding together two percutaneous lead bodies, resulting in the functional equivalent of a surgical lead body. The inventive medical lead body forms columns of electrodes which are either adjacent to or offset from each other, thus forming an array of electrodes. The bonding of the percutaneous lead bodies is accomplished by a plurality of urethane bridges molded to each of the percutaneous lead bodies. The plurality of bridges provides structural integrity to the medical lead yet permits the desired flexibility of the lead body. One side of the inventive medical lead body is "masked" or coated with a suitable non-conductive material. The masking of one side of the medical lead body makes that side of the lead body non-conductive and effectively directs the stimulation signals transmitting from the cylindrical electrodes toward the desired stimulated area for focused stimulation. In contrast to the surgical lead body, the medical lead body of the present invention may be percutaneously implanted. The percutaneous implantation is achieved by inserting the inventive medical lead body through a modified Tuohy needle having an oblong cross-section or other similar needle, such as, the needle disclosed in U.S. Patent Application Serial No. 09/303,045, which is incorporated herein by reference. Examples of the more important features of this invention have been broadly outlined above in order that the detailed description which follows may be better understood and so that contributions which this invention provide to the art may be better appreciated. There are, of course, additional features of the invention which will be described herein and which will be included within the subject matter of the claims appended hereto.
BRIEF DESCRIPTION OF THE DRAWINGS
The preferred embodiments of the invention will be described in relation to the accompanying drawings. In the drawings, the following figures have the following general nature:
Fig. 1 is an isometric view of the surgical lead of the present invention. Fig. 2 is an enlarged isometric view of the lead of Fig. 1 illustrating the position of the electrodes and the urethane bridge.
Fig. 3 is an enlarged isometric view of an alternative embodiment of the lead of Fig. 1. Fig. 4 is an enlarged isometric view of one of the percutaneous lead bodies of Fig. 1 illustrating a possible location of the non-conductive coating (the coating is slightly removed for clarity).
Fig. 5 is an enlarged cross-section view of Fig. 2 taken at line 5-5 illustrating a possible location of the non-conductive coating.
Fig. 6 is an enlarged cross-section view of Fig. 2 taken at line 6-6 illustrating the urethane bridge.
Fig. 7 is an enlarged cross-section view of Fig. 2 taken at line 5-5 illustrating an alternative location and application of the non-conductive coating (the coating is slightly removed for clarity).
In the accompanying drawings, like reference numbers are used throughout the various figures for identical structures.
DESCRIPTION OF THE PREFERRED EMBODIMENTS Referring to Figs. 1 and 2, there is disclosed a preferred embodiment of the medical lead 10 of the present invention useful for spinal cord, deep brain and peripheral nerve stimulation. The inventive medical lead 10 has a sufficiently small cross-section so as to permit percutaneous implantation of the lead at a targeted stimulation area via a modified Tuohy needle having an oblong cross-section. Significantly, the medical lead 10 provides the advantages of a surgical paddle-type lead, such as, better stimulation coverage and improved stability, without a physician or anesthesiologist having to perform a laminotomy or other similar surgical procedure to implant the medical lead.
As depicted in the figures, the medical lead 10 includes a pair of percutaneous lead bodies 12, 14 which are joined together in parallel relation along the edges of each lead. Note that the lead bodies 12, 14 may be molded as a one-piece body depending on desired rigidity of the lead 10, more fully discussed below. As conventional, each of the lead bodies 12, 14 define a cylindrical lead body and a round end. The lead body is made from polyurethane or other suitable material. Spaced along each of the lead bodies 12, 14 is at least one electrode 16 to provide electrical stimulation to the targeted nerve tissue. Each electrode is typically cylindrical in shape and thus provides stimulation in all directions away from the lead body. It should be understood that other shapes and types of electrodes may be used with the present invention and still be considered to be within the scope of the same. Each of the lead bodies 12, 14 further include at least one wire conductor, not shown, connected to the electrodes. As conventional, each wire conductor of the lead bodies
12, 14 may be coupled to an implantable neurological pulse generator, additional, intermediate wiring, or other stimulation device. The stimulation pulses produced by the implantable neurological pulse generator or other stimulation device are carried from the pulse generator through the wire conductors to the electrodes in each lead body 12, 14 and out to the targeted tissue. The plurality of electrodes permits varying stimulation of the targeted area. That is, one or more of the electrodes on the lead bodies 12, 14 transmit the stimulation pulses to targeted human tissue depending on the desired stimulation.
As depicted, the percutaneous lead bodies 12, 14 are joined in parallel relation and bonded together by a urethane material, such as polyurethane or other suitable material. The bonding is preferably achieved by a plurality of urethane bridges 20 spaced along the lead bodies. It should be noted that other attachments or means for bonding the lead bodies may be used with the present invention. The preferred urethane bridges 20 are molded to the lead bodies 12, 14 through a heating process not pertinent to the present invention. The spaced apart location of the bridges 20 creates a sufficiently rigid lead assembly that may be inserted through the needle and yet is flexible for enhanced positioning at the targeted area for effective stimulation coverage. The number and location of the urethane bridges will vary depending on the desired rigidity or flexibility of the medical lead 10 and these variations are considered to be within the scope of the present invention. Note that the percutaneous lead bodies 12, 14 may be molded as a single lead, thereby effectively creating a single, continuous urethane bridge between the lead bodies, a bridge extending the full length of the lead bodies 12, 14.
As illustrated in Fig. 2, there is shown one embodiment of the positioning of the percutaneous lead body 12 relative to the percutaneous lead body 14 for controlled orientation of the electrodes 16 of the lead bodies. As depicted, the electrodes 16 on lead body 12 are positioned substantially adjacent to the electrodes 16 on lead body 14. Adjacent electrodes may be in contact with each other or may be spaced apart from each other. Note that the contacting electrodes may be in physical contact with each other but not in electrical contact due to masking of one of the electrodes between the adjacent electrodes, as exemplified in Fig. 5. The lead bodies 12, 14 carrying the contacting electrodes may be connected to each other via one or more urethane bridges. Alternatively, the lead bodies may be connected via a single continuous urethane bridge, as described above. In the same manner, the lead bodies 12, 14 carrying the spaced apart electrodes may be connected to each other via either one or more urethane bridges or a single continuous bridge.
Alternatively, as shown in Fig. 3, the lead bodies 12, 14 may be positioned such that the electrodes 16 are off-set or staggered relative to each other. Again, the urethane bridges are positioned between the electrodes. Depending on the desired rigidity of the lead 10, the embodiment of staggered electrodes creates a more rigid structure than the embodiment where the electrodes are positioned adjacent to each other. As stated above, the number and location of the urethane bridges further affects the rigidity of the lead 10. In either embodiment, however, the electrodes form an array and are spaced both laterally and longitudinally from each, similar to a surgical paddle-type lead. This array provides the advantages of the surgical lead, namely, stimulation coverage of a larger targeted area and varying stimulation of the nerve tissue.
The medical lead 10 of the present invention defines two sides. As exemplified in Figure 4, applied to either of the sides is a non-conductive coating 18, preferably a polyurethane, parylene, or similar type coating or paint. The non- conductive coating applied to a portion of the medical lead 10, and specifically the electrode, renders that surface non-conductive. This has the effect of directing the stimulation signal toward the conductive side — the side opposite the coated side — for focused stimulation. Significantly, by coating one side of the medical lead 10 to focus the electrical signal, the lead functions in a manner similar to the surgical paddle-type lead where the electrical signal is transmitted in only one direction. It should be understood that depending on the desired stimulation, the amount of coating and the electrode area covered by the coating may vary, as exemplified in Fig. 7. In operation, the medical lead 10 is implanted with the non-coated side of the medical lead 10 placed adjacent to the targeted tissue.
The preferred embodiments of the invention are now described so as to enable a person of ordinary skill in the art to make and use the same. Variations of the preferred embodiments are possible without being outside the scope of the present invention. As an example, one or more percutaneous lead bodies may be bonded to either of the percutaneous lead bodies 12, 14. These additional lead bodies may be bonded in a manner similar to the bonding described above. Alternatively, a third percutaneous lead body may be percutaneously positioned alongside the bonded lead bodies 12, 14 and may be used to provide electrical stimulation similar to that taught by the Holsheimer model disclosed in U.S. Patent Nos. 5,501,703 and 5,643,330, both owned by Medtronic, Inc. of Minneapolis, MN, and both incorporated herein by reference. Therefore, to particularly point out and distinctly claim the subject matter regarded as the invention, the following claims conclude the specification.

Claims

What is claimed is:
1. A controlled orientation stimulation lead for percutaneous implantation, comprising: a first lead body having at least one electrode extending around the periphery of the first lead body; a second lead body attached to the first lead body, the second lead body having at least one electrode extending around the periphery of the second lead body; a first lead side formed from the first lead body attached to the second lead body, the first lead side having a first stimulation pattern; and a second lead side opposite the first lead side having a second stimulation pattern that is orientatable to a preselected stimulation site.
2. The controlled orientation stimulation lead as in claim 1 wherein at least one electrode on the first lead body is substantially adjacent to at least one electrode on the second lead body.
3. The controlled orientation stimulation lead as in claim 1 , further comprising masking around a portion of at least one electrode.
4. The controlled orientation stimulation lead as in claim 3 wherein the masking configures the stimulation pattern of the electrode.
5. The controlled orientation stimulation lead as in claim 3 wherein the masking electrically insulates at least one electrode on a first lead body from at least one electrode on a second lead body.
6. The controlled orientation stimulation lead as in claim 1 wherein stimulation lead stiffness is controlled by attachments between the first lead body and the second lead body.
7. An implantable medical lead for electrical stimulation at a targeted stimulation area, the medical lead defining a first and second side, comprising: a first percutaneous lead body having at least one electrode, a second percutaneous lead body bonded to the first percutaneous lead body, the second percutaneous lead body also having at least one electrode, and a non-conductive coating applied to at least a portion of either of the first or second sides of the medical lead, whereby the medical lead may be percutaneously implanted at the targeted stimulation area.
8. The implantable medical lead of claim 7 wherein the first and second percutaneous lead bodies are bonded together by a urethane material.
9. The implantable medical lead of claim 7 wherein the at least one electrode of the first percutaneous lead body is positioned off-set to the at least one electrode of the second percutaneous lead body.
10. The implantable medical lead of claim 8 wherein the bonding of the first and second percutaneous lead bodies is effected by multiple bridges of the urethane material.
11. The implantable medical lead of claim 7 wherein the first and second percutaneous lead bodies are bonded together by a continuous urethane bridge.
12. The implantable medical lead of claim 7 wherein the non-conductive coating is polyurethane.
13. A method of forming a surgical lead body comprising the steps of: providing a first percutaneous lead body having at least one electrode, providing a second percutaneous lead body having at least one electrode, bonding the first percutaneous lead body to the second percutaneous lead body to form the surgical lead body, the surgical lead body defining a first side and a second side, and coating either of the first or second side of the surgical lead body with a urethane material, whereby the surgical lead body may be percutaneously implanted.
14. The method of claim 13 wherein the bonding of the first and second percutaneous lead bodies is accomplished by a plurality of urethane bridges molded to the percutaneous lead bodies.
15. The method of claim 13 further comprising the step of positioning the plurality of electrodes on the first percutaneous lead body adjacent to the plurality of electrodes on the second percutaneous lead body prior to bonding.
16. A method of implanting a surgical lead body comprising the steps of: providing a first percutaneous lead body having at least one electrode, providing a second percutaneous lead body having at least one electrode, bonding the first percutaneous lead body to the second percutaneous lead body to form the surgical lead body, the surgical lead body defining a first side and a second side, coating either of the first or second side of the surgical lead body with a urethane material, inserting a needle having an opening to a targeted stimulation area, inserting the surgical lead body through the opening of the needle to the targeted stimulation area, and removing the needle from the targeted stimulation area.
17. The method of claim 16 further comprising the step of inserting the surgical lead body such that the side other than the first or second side having the coating is adjacent to the targeted stimulation area.
18. The method of claim 16 further comprising the step of positioning the at least one electrode on the first and second percutaneous lead bodies off-set to each other prior to bonding.
19. The method of claim 16 wherein the bonding of the first and second percutaneous lead bodies is accomplished by a plurality of urethane bridges molded to the percutaneous lead bodies.
20. The method of claim 16 further comprising the step of positioning the at least one electrode on the first and second percutaneous lead bodies adjacent to each other prior to bonding.
PCT/US2001/001559 2000-02-08 2001-01-16 Implantable stimulation lead WO2001058519A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DE60111723T DE60111723T2 (en) 2000-02-08 2001-01-16 IMPLANT PUNCHING
EP01951125A EP1257320B1 (en) 2000-02-08 2001-01-16 Implantable stimulation lead

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/500,201 US6587733B1 (en) 2000-02-08 2000-02-08 Percutaneous surgical lead body with directed stimulation
US09/500,201 2000-02-08

Publications (2)

Publication Number Publication Date
WO2001058519A1 true WO2001058519A1 (en) 2001-08-16
WO2001058519A9 WO2001058519A9 (en) 2002-10-17

Family

ID=23988446

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/001559 WO2001058519A1 (en) 2000-02-08 2001-01-16 Implantable stimulation lead

Country Status (4)

Country Link
US (2) US6587733B1 (en)
EP (2) EP1257320B1 (en)
DE (2) DE60111723T2 (en)
WO (1) WO2001058519A1 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7047084B2 (en) 2002-11-20 2006-05-16 Advanced Neuromodulation Systems, Inc. Apparatus for directionally stimulating nerve tissue
US7212867B2 (en) 2000-12-07 2007-05-01 Medtronic, Inc. Directional brain stimulation and recording leads
EP1870127A1 (en) * 2006-06-19 2007-12-26 Lifestim S.r.l. Electrical catheter for use in neurostimulation with adaptable neurostimulating tip
US7437197B2 (en) 2003-10-23 2008-10-14 Medtronic, Inc. Medical lead and manufacturing method therefor
US7499755B2 (en) 2002-10-23 2009-03-03 Medtronic, Inc. Paddle-style medical lead and method
US7797057B2 (en) 2002-10-23 2010-09-14 Medtronic, Inc. Medical paddle lead and method for spinal cord stimulation
EP2785415A4 (en) * 2011-10-07 2015-06-17 Anthony J Colantonio Lead coupler for multiple neurological stimulation leads
US9084872B2 (en) 2005-06-09 2015-07-21 Medtronic, Inc. Introducer for therapy delivery elements
US9687637B2 (en) 2003-08-29 2017-06-27 Medtronic, Inc. Percutaneous flat lead introducer

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7072719B2 (en) * 2001-09-20 2006-07-04 Medtronic, Inc. Implantable percutaneous stimulation lead with interlocking elements
US7128739B2 (en) * 2001-11-02 2006-10-31 Vivant Medical, Inc. High-strength microwave antenna assemblies and methods of use
US6878147B2 (en) 2001-11-02 2005-04-12 Vivant Medical, Inc. High-strength microwave antenna assemblies
US20050004639A1 (en) * 2003-07-03 2005-01-06 Advanced Neuromodulation Systems, Inc. Medical lead with resorbable material
US7311703B2 (en) 2003-07-18 2007-12-25 Vivant Medical, Inc. Devices and methods for cooling microwave antennas
US6925334B1 (en) * 2003-08-04 2005-08-02 Pacesetter, Inc. Implantable medical lead having multiple, jointly insulated electrical conductors
US20050049663A1 (en) * 2003-08-29 2005-03-03 Harris Charmaine K. Percutaneous flat lead introducer
US7392093B2 (en) * 2003-09-26 2008-06-24 Advanced Neuromodulation Systems, Inc. Electrical stimulation system including a device for partially shielding electrical energy emitted from one or more electrical stimulation leads implanted in a human's body
WO2005032650A1 (en) * 2003-10-03 2005-04-14 Medtronic, Inc. Kit for implantation of therapy elements
US20050159799A1 (en) 2003-11-25 2005-07-21 Advanced Neuromodulation Systems, Inc. Percutaneous-insertion needle and method of implanting a lead
US8060207B2 (en) 2003-12-22 2011-11-15 Boston Scientific Scimed, Inc. Method of intravascularly delivering stimulation leads into direct contact with tissue
US20050137646A1 (en) * 2003-12-22 2005-06-23 Scimed Life Systems, Inc. Method of intravascularly delivering stimulation leads into brain
US7295875B2 (en) * 2004-02-20 2007-11-13 Boston Scientific Scimed, Inc. Method of stimulating/sensing brain with combination of intravascularly and non-vascularly delivered leads
US20050203600A1 (en) 2004-03-12 2005-09-15 Scimed Life Systems, Inc. Collapsible/expandable tubular electrode leads
US7590454B2 (en) * 2004-03-12 2009-09-15 Boston Scientific Neuromodulation Corporation Modular stimulation lead network
US7231260B2 (en) * 2004-05-06 2007-06-12 Boston Scientific Scimed, Inc. Intravascular self-anchoring electrode body with arcuate springs, spring loops, or arms
US7286879B2 (en) 2004-07-16 2007-10-23 Boston Scientific Scimed, Inc. Method of stimulating fastigium nucleus to treat neurological disorders
US9079018B2 (en) 2004-10-21 2015-07-14 Medtronic, Inc. Implantable medical electrical leads, kits, systems and methods of use thereof
US9050455B2 (en) 2004-10-21 2015-06-09 Medtronic, Inc. Transverse tripole neurostimulation methods, kits and systems
US7937160B2 (en) 2004-12-10 2011-05-03 Boston Scientific Neuromodulation Corporation Methods for delivering cortical electrode leads into patient's head
EP1848496B1 (en) 2005-01-31 2009-11-18 Medtronic, Inc. Method of manufacturing a medical lead
US7799019B2 (en) 2005-05-10 2010-09-21 Vivant Medical, Inc. Reinforced high strength microwave antenna
US20070112402A1 (en) * 2005-10-19 2007-05-17 Duke University Electrode systems and related methods for providing therapeutic differential tissue stimulation
US20070118198A1 (en) * 2005-11-07 2007-05-24 Prager Joshua P Neurostimulation lead with concentric electrodes
US7763034B2 (en) * 2006-01-24 2010-07-27 Medtronic, Inc. Transobturator lead implantation for pelvic floor stimulation
US20070282410A1 (en) * 2006-04-28 2007-12-06 Cross Thomas E Jr Implantable medical lead assemblies with improved flexibility and extensibility and having a substantially two-dimensional nature
US7617006B2 (en) * 2006-04-28 2009-11-10 Medtronic, Inc. Medical electrical lead for spinal cord stimulation
US20080051861A1 (en) * 2006-04-28 2008-02-28 Cross Thomas E Implantable medical assemblies with improved flexibility, extensibility and positionability with branched structures
US20080039917A1 (en) * 2006-04-28 2008-02-14 Cross Thomas E Implantable medical leads and lead assemblies with improved flexibility and extensibility to facilitate body movements
US7515968B2 (en) 2006-04-28 2009-04-07 Medtronic, Inc. Assembly method for spinal cord stimulation lead
US7684873B2 (en) * 2006-10-31 2010-03-23 Medtronic, Inc. Implantable medical lead including a directional electrode and fixation elements along an interior surface
US8688238B2 (en) 2006-10-31 2014-04-01 Medtronic, Inc. Implantable medical elongated member including fixation elements along an interior surface
US7774072B2 (en) * 2006-11-30 2010-08-10 Medtronic, Inc. Attached implantable medical elongated members
US7797054B2 (en) * 2007-01-12 2010-09-14 Medtronic, Inc. Expandable systems for medical electrical stimulation
US7998139B2 (en) * 2007-04-25 2011-08-16 Vivant Medical, Inc. Cooled helical antenna for microwave ablation
US9399130B2 (en) * 2007-04-25 2016-07-26 Medtronic, Inc. Cannula configured to deliver test stimulation
US9561053B2 (en) * 2007-04-25 2017-02-07 Medtronic, Inc. Implant tool to facilitate medical device implantation
US8954162B2 (en) * 2007-04-25 2015-02-10 Medtronic, Inc. Medical device implantation
US20080269857A1 (en) * 2007-04-30 2008-10-30 Cross Thomas E Implantable medical leads and lead assemblies with flexibility, extensibility and branched structures
US7725198B2 (en) * 2007-04-30 2010-05-25 Medtronic, Inc. Implantable medical lead assemblies with delivery tether
US7996090B2 (en) * 2007-04-30 2011-08-09 Medtronic, Inc. Methods of making implantable medical leads with a non-linear shape
US20080269858A1 (en) * 2007-04-30 2008-10-30 Cross Thomas E Implantable medical leads with flexibility and extensibility, and having a substantially two-dimensional nature
US20080269837A1 (en) * 2007-04-30 2008-10-30 Christy Ludlow Implantable medical lead for implantation in a patient, such as a patient's neck
US20080269856A1 (en) * 2007-04-30 2008-10-30 Cross Thomas E Implantable medical leads with flexibility and extensibility to facilitate body movements
US8353901B2 (en) 2007-05-22 2013-01-15 Vivant Medical, Inc. Energy delivery conduits for use with electrosurgical devices
US9023024B2 (en) 2007-06-20 2015-05-05 Covidien Lp Reflective power monitoring for microwave applications
US8090450B2 (en) * 2007-06-27 2012-01-03 Greatbatch Ltd. Percutaneous electrode array and system
US8600518B2 (en) 2008-04-30 2013-12-03 Boston Scientific Neuromodulation Corporation Electrodes for stimulation leads and methods of manufacture and use
US20090318986A1 (en) * 2008-06-20 2009-12-24 Alo Kenneth M Systems, Methods and Apparatus for Treating Cardiac Dysfunction with Neurostimulation
EP3173125B1 (en) 2008-07-30 2019-03-27 Ecole Polytechnique Fédérale de Lausanne Apparatus for optimized stimulation of a neurological target
EP2382008B1 (en) 2008-11-12 2015-04-29 Ecole Polytechnique Federale De Lausanne Microfabricated neurostimulation device
US8406896B2 (en) * 2009-06-29 2013-03-26 Boston Scientific Neuromodulation Corporation Multi-element contact assemblies for electrical stimulation systems and systems and methods of making and using
US20110009933A1 (en) * 2009-07-09 2011-01-13 Boston Scientific Neuromodulation Corporation Piggy-back percutaneous lead insertion kit
US11045221B2 (en) 2009-10-30 2021-06-29 Medtronic, Inc. Steerable percutaneous paddle stimulation lead
CA2782710C (en) 2009-12-01 2019-01-22 Ecole Polytechnique Federale De Lausanne Microfabricated neurostimulation device and methods of making and using the same
ES2562982T3 (en) * 2010-03-23 2016-03-09 Boston Scientific Neuromodulation Corporation Helical radial separation of contacts in a cylindrical conductor
US9549708B2 (en) 2010-04-01 2017-01-24 Ecole Polytechnique Federale De Lausanne Device for interacting with neurological tissue and methods of making and using the same
US8965482B2 (en) 2010-09-30 2015-02-24 Nevro Corporation Systems and methods for positioning implanted devices in a patient
US8805519B2 (en) 2010-09-30 2014-08-12 Nevro Corporation Systems and methods for detecting intrathecal penetration
US9265934B2 (en) * 2010-12-03 2016-02-23 Boston Scientific Neuromodulation Corporation Percutaneously implantable paddle-type lead and methods and devices for deployment
WO2012141960A1 (en) * 2011-04-11 2012-10-18 Boston Scientific Neuromodulation Corporation Systems and methods for enhancing paddle lead placement
WO2013003368A1 (en) 2011-06-28 2013-01-03 Boston Scientific Neuromodulation Corporation System and method for using impedance to determine proximity and orientation of segmented electrodes
EP2763743A4 (en) 2011-10-04 2015-08-05 Nevro Corp Modeling positions of implanted devices in a patient
WO2013147984A1 (en) 2012-03-30 2013-10-03 Medtronic, Inc. Medical system lead adapter providing for customized stimulation pattern for a secondary lead
EP2838609B1 (en) * 2012-04-19 2019-03-06 Medtronic, Inc. Paired medical lead bodies with braided conductive shields having different physical parameter values
US11311718B2 (en) 2014-05-16 2022-04-26 Aleva Neurotherapeutics Sa Device for interacting with neurological tissue and methods of making and using the same
WO2015173787A1 (en) 2014-05-16 2015-11-19 Aleva Neurotherapeutics Sa Device for interacting with neurological tissue and methods of making and using the same
US9925376B2 (en) 2014-08-27 2018-03-27 Aleva Neurotherapeutics Treatment of autoimmune diseases with deep brain stimulation
US9474894B2 (en) 2014-08-27 2016-10-25 Aleva Neurotherapeutics Deep brain stimulation lead
US9403011B2 (en) 2014-08-27 2016-08-02 Aleva Neurotherapeutics Leadless neurostimulator
US10328271B2 (en) 2015-11-12 2019-06-25 Medtronic, Inc. Implantable electrical stimulator with deflecting tip lead
US10980999B2 (en) 2017-03-09 2021-04-20 Nevro Corp. Paddle leads and delivery tools, and associated systems and methods
US10702692B2 (en) 2018-03-02 2020-07-07 Aleva Neurotherapeutics Neurostimulation device
EP3758793A4 (en) 2018-03-29 2021-12-08 Nevro Corp. Leads having sidewall openings, and associated systems and methods

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0580928A1 (en) * 1992-07-31 1994-02-02 ARIES S.r.l. A spinal electrode catheter
EP0862925A2 (en) * 1997-03-03 1998-09-09 Medtronic, Inc. Sacral medical electrical lead
US5895416A (en) * 1997-03-12 1999-04-20 Medtronic, Inc. Method and apparatus for controlling and steering an electric field
WO1999056818A1 (en) * 1998-04-30 1999-11-11 Medtronic, Inc. Multiple electrode lead body for spinal cord stimulation

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3474791A (en) 1966-03-24 1969-10-28 Brunswick Corp Multiple conductor electrode
US3646940A (en) 1969-07-15 1972-03-07 Univ Minnesota Implantable electronic stimulator electrode and method
DE2319054C3 (en) 1973-04-14 1980-03-06 Hans Dr.Med. Stockholm Lagergren Electrode arrangement
US4744370A (en) 1987-04-27 1988-05-17 Cordis Leads, Inc. Lead assembly with selectable electrode connection
US5127403A (en) 1988-07-05 1992-07-07 Cardiac Control Systems, Inc. Pacemaker catheter utilizing bipolar electrodes spaced in accordance to the length of a heart depolarization signal
US5000194A (en) 1988-08-25 1991-03-19 Cochlear Corporation Array of bipolar electrodes
US4961434A (en) 1988-08-30 1990-10-09 Stypulkowski Paul H Array of recessed radially oriented bipolar electrodes
US5251634A (en) * 1991-05-03 1993-10-12 Cyberonics, Inc. Helical nerve electrode
US5423877A (en) 1992-05-04 1995-06-13 David C. Mackey Method and device for acute pain management by simultaneous spinal cord electrical stimulation and drug infusion
SE9300469D0 (en) 1993-02-12 1993-02-12 Siemens Elema Ab The electrode device
US5501703A (en) 1994-01-24 1996-03-26 Medtronic, Inc. Multichannel apparatus for epidural spinal cord stimulator
US5649970A (en) 1995-08-18 1997-07-22 Loeb; Gerald E. Edge-effect electrodes for inducing spatially controlled distributions of electrical potentials in volume conductive media
US5628779A (en) * 1996-04-03 1997-05-13 Pacesetter, Inc. Single-pass A-V pacing lead
US5702429A (en) 1996-04-04 1997-12-30 Medtronic, Inc. Neural stimulation techniques with feedback
US5702437A (en) 1996-04-10 1997-12-30 Medtronic Inc. Implantable lead with wires carried by body
US5697951A (en) 1996-04-25 1997-12-16 Medtronic, Inc. Implantable stimulation and drug infusion techniques
US5713923A (en) 1996-05-13 1998-02-03 Medtronic, Inc. Techniques for treating epilepsy by brain stimulation and drug infusion
US5843148A (en) 1996-09-27 1998-12-01 Medtronic, Inc. High resolution brain stimulation lead and method of use
US5865843A (en) 1997-04-23 1999-02-02 Medtronic Inc. Medical neurological lead with integral fixation mechanism
US6212434B1 (en) * 1998-07-22 2001-04-03 Cardiac Pacemakers, Inc. Single pass lead system
US6141594A (en) * 1998-07-22 2000-10-31 Cardiac Pacemakers, Inc. Single pass lead and system with active and passive fixation elements
US5919222A (en) 1998-01-06 1999-07-06 Medtronic Inc. Adjustable medical electrode lead
US6011996A (en) 1998-01-20 2000-01-04 Medtronic, Inc Dual electrode lead and method for brain target localization in functional stereotactic brain surgery
US6205361B1 (en) * 1998-02-10 2001-03-20 Advanced Bionics Corporation Implantable expandable multicontact electrodes
US6134478A (en) 1998-06-05 2000-10-17 Intermedics Inc. Method for making cardiac leads with zone insulated electrodes
US6240320B1 (en) 1998-06-05 2001-05-29 Intermedics Inc. Cardiac lead with zone insulated electrodes
US6493590B1 (en) 2000-02-09 2002-12-10 Micronet Medical, Inc. Flexible band electrodes for medical leads
US6510347B2 (en) 2000-08-17 2003-01-21 William N. Borkan Spinal cord stimulation leads

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0580928A1 (en) * 1992-07-31 1994-02-02 ARIES S.r.l. A spinal electrode catheter
EP0862925A2 (en) * 1997-03-03 1998-09-09 Medtronic, Inc. Sacral medical electrical lead
US5895416A (en) * 1997-03-12 1999-04-20 Medtronic, Inc. Method and apparatus for controlling and steering an electric field
WO1999056818A1 (en) * 1998-04-30 1999-11-11 Medtronic, Inc. Multiple electrode lead body for spinal cord stimulation

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7212867B2 (en) 2000-12-07 2007-05-01 Medtronic, Inc. Directional brain stimulation and recording leads
US7499755B2 (en) 2002-10-23 2009-03-03 Medtronic, Inc. Paddle-style medical lead and method
US7797057B2 (en) 2002-10-23 2010-09-14 Medtronic, Inc. Medical paddle lead and method for spinal cord stimulation
US7047084B2 (en) 2002-11-20 2006-05-16 Advanced Neuromodulation Systems, Inc. Apparatus for directionally stimulating nerve tissue
US9687637B2 (en) 2003-08-29 2017-06-27 Medtronic, Inc. Percutaneous flat lead introducer
US10173040B2 (en) 2003-08-29 2019-01-08 Medtronic, Inc. Percutaneous flat lead introducer
US7437197B2 (en) 2003-10-23 2008-10-14 Medtronic, Inc. Medical lead and manufacturing method therefor
US9084872B2 (en) 2005-06-09 2015-07-21 Medtronic, Inc. Introducer for therapy delivery elements
EP1870127A1 (en) * 2006-06-19 2007-12-26 Lifestim S.r.l. Electrical catheter for use in neurostimulation with adaptable neurostimulating tip
EP2785415A4 (en) * 2011-10-07 2015-06-17 Anthony J Colantonio Lead coupler for multiple neurological stimulation leads

Also Published As

Publication number Publication date
DE60111723T2 (en) 2006-06-01
DE60111723D1 (en) 2005-08-04
EP1257320B1 (en) 2005-06-29
EP1257320A1 (en) 2002-11-20
DE60124021T2 (en) 2007-05-03
US6587733B1 (en) 2003-07-01
US20030229387A1 (en) 2003-12-11
EP1514576B1 (en) 2006-10-18
WO2001058519A9 (en) 2002-10-17
EP1514576A1 (en) 2005-03-16
DE60124021D1 (en) 2006-11-30
US7319904B2 (en) 2008-01-15

Similar Documents

Publication Publication Date Title
US6587733B1 (en) Percutaneous surgical lead body with directed stimulation
US8233993B2 (en) Winged electrode body for spinal cord stimulation
EP1370322B1 (en) Lead with adjustable angular and spatial relationships between electrodes
US9610435B2 (en) Anchoring units for implantable electrical stimulation systems and methods of making and using
AU726391B2 (en) High resolution brain stimulation lead and method of use
US6304787B1 (en) Cochlear electrode array having current-focusing and tissue-treating features
US8983625B2 (en) Systems and methods for electrically stimulating patient tissue on or around one or more bony structures
US6862805B1 (en) Method of making a cochlear electrode array having current-focusing and tissue-treating features
US7930037B2 (en) Field steerable electrical stimulation paddle, lead system, and medical device incorporating the same
US20020111661A1 (en) Multiple electrode lead body for spinal cord stimulation
US20100076534A1 (en) Malleable needle having a plurality of electrodes for facilitating implantation of stimulation lead and method of implanting an electrical stimulation lead
US8805544B2 (en) Insertion tool for paddle-style electrode
US9020608B2 (en) Implantable paddle lead comprising stretching electrical traces and method of fabrication
EP2996762A1 (en) Electrical stimulation leads and systems with anchoring units and methods of making and using
US20180021569A1 (en) Systems and methods for making and using an electrical stimulation system for stimulation of dorsal root ganglia
US6546293B2 (en) Hook-shaped spinal cord electrode assembly having a telescoping electrode
EP3574952B1 (en) An electrode array, a lead paddle and a neuromodulation system
EP4257176A1 (en) Device and method for electrically stimulating at least one nerve
US10124161B2 (en) Neurostimulation lead with conductive elements and methods for making the same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2001951125

Country of ref document: EP

AK Designated states

Kind code of ref document: C2

Designated state(s): JP

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

COP Corrected version of pamphlet

Free format text: PAGE 1/1, DRAWINGS, REPLACED BY A NEW PAGE 1/1; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

WWP Wipo information: published in national office

Ref document number: 2001951125

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWG Wipo information: grant in national office

Ref document number: 2001951125

Country of ref document: EP